These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35753029)

  • 1. Discrepancy between biomarkers of lung injury and 1-year mortality in COVID-19.
    Atalay B; Cesur A; Agirbasli M
    Eur J Clin Invest; 2022 Sep; 52(9):e13827. PubMed ID: 35753029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of biomarker levels and chest imaging in patients with COVID-19 presenting to the emergency department.
    Dagher GA; Ghanem AA; Haidar S; Kattouf N; Assaf M; Khdhir M; Chahine R; Rizk J; Makki M; Tamim H; Chebl RB
    Am J Emerg Med; 2022 Sep; 59():15-23. PubMed ID: 35772223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
    Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
    Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and short-term prognosis in COVID-19.
    Peiró ÓM; Carrasquer A; Sánchez-Gimenez R; Lal-Trehan N; Del-Moral-Ronda V; Bonet G; Fort-Gallifa I; Picó-Plana E; Bastón-Paz N; Gutiérrez C; Bardaji A
    Biomarkers; 2021 Mar; 26(2):119-126. PubMed ID: 33426934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing Correlation of Clinical Severity of COVID-19 with Other Biochemical Parameters: A Retrospective Study from Pakistan.
    Hassan Shah SST; Naeem I; Wahid B
    Tohoku J Exp Med; 2021 Dec; 255(4):315-323. PubMed ID: 34911879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining extent of COVID-19 pneumonia on CT based on biological variables.
    Tordjman M; Mekki A; Mali RD; Monnier H; Neveu S; Chassagnon G; Mihoubi F; Carlier N; Marey J; Fournier L; Carlier RY; Drapé JL; Revel MP
    Respir Med; 2020 Dec; 175():106206. PubMed ID: 33166904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients.
    Wang L; Yang LM; Pei SF; Chong YZ; Guo Y; Gao XL; Tang QY; Li Y; Feng FM
    Scand J Clin Lab Invest; 2021 Dec; 81(8):679-686. PubMed ID: 34762008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.
    Serin I; Sari ND; Dogu MH; Acikel SD; Babur G; Ulusoy A; Onar MI; Gokce EC; Altunok O; Yaylaci Mert F; Karakilic A; Baltik M; Gulesir B
    J Infect Public Health; 2020 Nov; 13(11):1664-1670. PubMed ID: 33071210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 16. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 18. ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19.
    Bousquet G; Falgarone G; Deutsch D; Derolez S; Lopez-Sublet M; Goudot FX; Amari K; Uzunhan Y; Bouchaud O; Pamoukdjian F
    Aging (Albany NY); 2020 Jun; 12(12):11306-11313. PubMed ID: 32576712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Dimer as a potential biomarker for disease severity in COVID-19.
    Ozen M; Yilmaz A; Cakmak V; Beyoglu R; Oskay A; Seyit M; Senol H
    Am J Emerg Med; 2021 Feb; 40():55-59. PubMed ID: 33348224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.